Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Seelos Therapeutics (SEEL)
OTHER OTC:SEEL
Holding SEEL?
Track your performance easily
SEEL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.67 - $702.60
Previous Close$0.73
Volume15.12K
Average Volume (3M)577.57K
Market Cap
$820.61K
Enterprise Value$10.68M
Total Cash (Recent Filing)$300.00K
Total Debt (Recent Filing)$10.16M
Price to Earnings (P/E)<0.1
Beta1.77
Next Earnings
Apr 25, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)176.64
Shares Outstanding435,958
10 Day Avg. Volume25,950
30 Day Avg. Volume577,566
Standard Deviation0.35
R-Squared0.09
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)-0.01
Price to Sales (P/S)0.14
Price to Cash Flow (P/CF)-0.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.27
Enterprise Value/Gross Profit4.85
Enterprise Value/Ebitda-0.54
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Seelos Therapeutics News
PremiumCompany Announcements
Seelos Therapeutics Announces Reverse Stock Split and Adjustments
PremiumMarket News
3 Penny Stocks to Watch Now, 9/25/24Ownership Overview
42.56% Insiders
1.66% Mutual Funds
0.97% Other Institutional Investors
49.29% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
SEEL FAQ
What was Seelos Therapeutics’s price range in the past 12 months?
Seelos Therapeutics lowest stock price was $0.67 and its highest was $702.60 in the past 12 months.
What is Seelos Therapeutics’s market cap?
Currently, no data Available
When is Seelos Therapeutics’s upcoming earnings report date?
Seelos Therapeutics’s upcoming earnings report date is Apr 25, 2025 which is in 155 days.
How were Seelos Therapeutics’s earnings last quarter?
Seelos Therapeutics released its earnings results on Aug 02, 2024. The company reported $0.124 earnings per share for the quarter, beating the consensus estimate of N/A by $0.124.
Is Seelos Therapeutics overvalued?
According to Wall Street analysts Seelos Therapeutics’s price is currently Overvalued.
Does Seelos Therapeutics pay dividends?
Seelos Therapeutics does not currently pay dividends.
What is Seelos Therapeutics’s EPS estimate?
Seelos Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Seelos Therapeutics have?
Seelos Therapeutics has 1,124,121 shares outstanding.
What happened to Seelos Therapeutics’s price movement after its last earnings report?
Seelos Therapeutics reported an EPS of $0.124 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -20%.
Which hedge fund is a major shareholder of Seelos Therapeutics?
Among the largest hedge funds holding Seelos Therapeutics’s share is Woodline Partners LP. It holds Seelos Therapeutics’s shares valued at N/A.
---
Seelos Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
SEEL Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 189.0 Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days <0.1%
Last 30 Days ▼ 2.1%
Last 30 Days ▼ 2.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-99.86%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-79.97%
Trailing 12-Months
Company Description
Seelos Therapeutics
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system disorders. Its portfolio include late-stage clinical assets targeting psychiatric and movement disorders. The company is headquartered in New York, NY.
---
SEEL Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering SEEL
1 Year
1 Year Success Rate
0/5 ratings generated profit
1 Year Average Return
-99.60%
reiterated a buy rating 8 months ago
Copying Thomas Shrader's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -99.60% per trade.
---